Lemercier Jean-Luc M 4
4 · Edwards Lifesciences Corp · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Lemercier Jean-Luc M
CVP, EMEA, Canada, Latin Amer
Transactions
- Exercise/Conversion
Common Stock
2024-03-11$36.75/sh+14,400$529,200→ 187,983.779 total - Sale
Common Stock
2024-03-11$91.68/sh−14,400$1,320,149→ 173,583.779 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2024-03-11−14,400→ 28,800 totalExercise: $36.75From: 2018-05-11Exp: 2024-05-10→ Common Stock (14,400 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $91.4500 to $92.0075. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.